Amyloid PET-assisted diagnosis and improved outcomes: Biomarkering or biomarketing?
- PMID: 36752348
- DOI: 10.1002/alz.12936
Amyloid PET-assisted diagnosis and improved outcomes: Biomarkering or biomarketing?
Comment in
-
How to write a good embedded ethics letter.Account Res. 2024 Oct;31(7):976-977. doi: 10.1080/08989621.2023.2179920. Epub 2023 Feb 16. Account Res. 2024. PMID: 36786217 No abstract available.
Comment on
-
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting.Alzheimers Dement. 2023 May;19(5):2006-2013. doi: 10.1002/alz.12846. Epub 2022 Nov 23. Alzheimers Dement. 2023. PMID: 36419238
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical